AXNX
Axonics Modulation Technologies Inc
Price:  
70.98 
USD
Volume:  
4,178,632.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AXNX WACC - Weighted Average Cost of Capital

The WACC of Axonics Modulation Technologies Inc (AXNX) is 8.4%.

The Cost of Equity of Axonics Modulation Technologies Inc (AXNX) is 9.90%.
The Cost of Debt of Axonics Modulation Technologies Inc (AXNX) is 7.00%.

Range Selected
Cost of equity 7.70% - 12.10% 9.90%
Tax rate 0.60% - 2.30% 1.45%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.3% - 9.5% 8.4%
WACC

AXNX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.83 1.3
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 12.10%
Tax rate 0.60% 2.30%
Debt/Equity ratio 1 1
Cost of debt 7.00% 7.00%
After-tax WACC 7.3% 9.5%
Selected WACC 8.4%

AXNX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for AXNX:

cost_of_equity (9.90%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.83) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.